Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP646006.RAXUzc20f44-hD7unuPAGmh8MTXwadPH3V_IOlMbKpnss130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP646006.RAXUzc20f44-hD7unuPAGmh8MTXwadPH3V_IOlMbKpnss130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP646006.RAXUzc20f44-hD7unuPAGmh8MTXwadPH3V_IOlMbKpnss130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP646006.RAXUzc20f44-hD7unuPAGmh8MTXwadPH3V_IOlMbKpnss130_provenance.
- NP646006.RAXUzc20f44-hD7unuPAGmh8MTXwadPH3V_IOlMbKpnss130_assertion description "[The data suggest that p53 has opposing effects in gliomas treated with methylating or chloroethylating agents and, therefore, the p53 status should be taken into account when deciding which therapeutic drug to use.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP646006.RAXUzc20f44-hD7unuPAGmh8MTXwadPH3V_IOlMbKpnss130_provenance.
- NP646006.RAXUzc20f44-hD7unuPAGmh8MTXwadPH3V_IOlMbKpnss130_assertion evidence source_evidence_literature NP646006.RAXUzc20f44-hD7unuPAGmh8MTXwadPH3V_IOlMbKpnss130_provenance.
- NP646006.RAXUzc20f44-hD7unuPAGmh8MTXwadPH3V_IOlMbKpnss130_assertion SIO_000772 18089819 NP646006.RAXUzc20f44-hD7unuPAGmh8MTXwadPH3V_IOlMbKpnss130_provenance.
- NP646006.RAXUzc20f44-hD7unuPAGmh8MTXwadPH3V_IOlMbKpnss130_assertion wasDerivedFrom befree-2016 NP646006.RAXUzc20f44-hD7unuPAGmh8MTXwadPH3V_IOlMbKpnss130_provenance.
- NP646006.RAXUzc20f44-hD7unuPAGmh8MTXwadPH3V_IOlMbKpnss130_assertion wasGeneratedBy ECO_0000203 NP646006.RAXUzc20f44-hD7unuPAGmh8MTXwadPH3V_IOlMbKpnss130_provenance.
- befree-2016 importedOn "2016-02-19" NP646006.RAXUzc20f44-hD7unuPAGmh8MTXwadPH3V_IOlMbKpnss130_provenance.